Skip to main content
. 2022 May 31;127(5):948–956. doi: 10.1038/s41416-022-01832-4

Fig. 2. Ranking probabilities base on the multiple comparisons on ORR, PFS and OS in network meta-analysis.

Fig. 2

Ranking probabilities on ORR (a), PFS (b), and OS (c) in NSCLC patients with a high PD-L1 expression according to multiple comparisons. ICI immune checkpoint inhibitors, chemo-ICI ICI-combined chemotherapy.